Children mature B cell lymphoma clinical decision-making, teaching and scientific research auxiliary support system and method

Abstract

The invention discloses a clinical decision-making, teaching and scientific research auxiliary support system and a clinical decision-making, teaching and scientific research auxiliary support method for children aggressive mature B-cell lymphoma. The system and the method comprise a medical and pharmaceutical data storage unit, a diagnosis and treatment parameter storage unit, an information input unit, a comparison processor unit, a diagnosis and treatment result output unit and an early warning and operation recording unit which are matched. According to patient disease specificity information parameter values, feasible clinical diagnosis and treatment scheme suggestions and corresponding clinical research and real world research evidence support can be provided for related medical workers, and the whole disease cycle of screening diagnosis, treatment, monitoring follow-up visit, out-of-hospital management and the like is covered; doctors are assisted to quickly improve the clinical diagnosis and treatment level, learn and update diagnosis and treatment knowledge, master the research status and development direction of clinical research and real-world diagnosis and treatment, improve the scientific research level and solve the contradiction that time and energy of medical workers are difficult to follow the clinical research progress.

Description

technical field [0001] The invention belongs to the field of smart medical care, and further relates to a clinical decision-making, teaching, and scientific research auxiliary support system and method for children's aggressive mature B-cell lymphoma in the field of digital medical technology. Background technique [0002] According to the 2019 report of the National Cancer Center, it is estimated that there were about 3.929 million new cases of malignant tumors in China in 2015, and about 2.338 million deaths. The overall cancer burden in China is still on the rise, and the situation of cancer prevention and control is still severe. Among them, children's aggressive mature B-cell lymphoma, mainly including Burkitt's lymphoma and diffuse large B-cell lymphoma, is a type of lymphoma that is very harmful to children's health. Without treatment, the child may die quickly. In 2019, ten ministries and commissions including the National Health and Medical Commission issued the "H...

AI Technical Summary

Problems solved by technology

However, this invention is only aimed at the western medicine system and fails to achieve the integration of traditional Chinese and western medicine. Chinese patent medicines and traditional Chinese medicines are widely used in China, especially in grassroots medical institutions, which is a blind spot of existing decision-making assistance

In addition, the invention does not independently divide the diagnosis and treatment parameter library and does not systematically analyze and utilize disease-specific diagnosis and treatment parameters and their weight values, which is lacking in individualized decision-making assistance, teaching and scientific research support for specific diseases

[0005] At present, there is a lack of clinical decision support system for the full disease cycle of aggressive mature B-cell lymphoma in children, and it is impossible to provide targeted and specific clinical diagnosis and treatment assistance, teaching training support and scientific research for the full disease cycle of aggressive mature B-cell lymphoma in children support

Images